Patients with atherosclerosis today usually receive preventive treatment only after a heart attack or stroke because diagnostic methods that can identify individuals and atherosclerotic plaques with high-risk are lacking. In addition, the choice of treatment, both surgical and medical, is based on large patient studies and the possibilities for individualizing treatment are small.
